Systematic reviews - appraisal and synthesis of all primary research - are increasingly being used to inform policy and practice in health care. Therefore, it is important to understand how the key questions in systematic reviews are identified and prioritised and whether they are relevant to policy makers, practitioners and members of the public. Research priority setting (RPS) is usually defined as any interpersonal activity that leads to the selection of topics and/or choices of key questions to investigate . Diverse approaches to setting research priorities are used in different countries, regions and organisations. There is no consensus in the literature on the most effective processes with which to set these priorities. However, these decisions define the quality and implications of the evidence, and syntheses of it, available to patients, public and policy makers to help them make informed decisions. My initial scoping work, was to design and conduct a survey across an influential international systematic review organisation (Cochrane Collaboration ) on how they set priorities for their reviews. We identified 13 structured approaches to setting priorities. As part of the project, we developed an evaluation framework that demonstrated whether the priority setting processes meet the values and principles of the Cochrane Collaboration. Subsequently, we developed an equity lens for research priority setting exercises to inform the design of research priority setting processes to ensure that they consider the priorities of disadvantaged groups along with advantaged groups. We used the equity lens to do a second evaluation on the priority setting processes in the Cochrane Collaboration. Both evaluation frameworks demonstrated that the Cochrane Collaboration requires better designed priority setting approaches and must be more transparent in reporting those processes. The evaluation of research priority setting exercises in the Cochrane Collaboration, along with the wider literature, demonstrates that research priority setting exercises cannot be evaluated in isolation from organisational cultures, values and context. Therefore, the next step of the project focused on a specific stakeholder group (major research funders) with significant influence on research, including support for systematic reviews. We selected 11 national research agencies in the UK, Netherlands, France, Norway, Denmark, Germany, Australia, Canada, and the USA. We devised and used a checklist based on Chalmers and Glasziou’s “avoidable research waste” framework (and evaluated the processes and policies of these agencies using this checklist). As previous evaluations had demonstrated, this second evaluation found a lack of transparency in the process of setting priorities for research and other related organisational and policy issues. Increased funding is needed for methodological research to evaluate research practices and to monitor how funding research projects is done and reported. My evaluation of funding agencies and the Cochrane Collaboration found a similar lack of transparency and accountability in the context of conflicting values among stakeholders that decreases accountability and scrutiny of researchers and their institutions. However, the projects have led to organisational and policy changes in the two key stakeholder groups (the Cochrane Collaboration and selected funding agencies). Officials of national health research funding agencies have approached me to collaborate with them to address the issues raised by my work on reducing research waste. This led to the establishment of Funders Forum - the Ensuring Value in Research (EViR) Funders’ Collaboration and Development Forum - to enable agencies in various countries to exchange their experience in addressing issues and creating work groups to address them. The Forum is chaired by individuals from three major research funders: NIHR (UK), ZonMW (Netherlands) and Patient-Centered Outcomes Research Institute (PCORI; USA). The Forum organises several meetings to establish common principles, standards and work plans to achieve the common objective around reducing research waste and adding value for research for a national research funder.

Orientador: Vania dos Santos Nunes Nogueira / Resumo: Além das complicações agudas relacionadas à hiperglicemia, os pacientes com Diabetes Mellitus terão ao decorrer da vida várias complicações crônicas que juntas contribuirão para uma maior morbidade e mortalidade nesses indivíduos. A Polineuropatia Diabética Periférica (PND) é uma dessas complicações, que além dos sintomas de parestesia e hiperestesia, bem como vários tipos de dor espontânea, pode levar a diminuição do equilíbrio postural e aumento do risco de quedas. Objetivo: realizar uma revisão sistemática para avaliar a eficácia do exercício físico pré-programado e supervisionado no tratamento complementar da PND. Métodos: foram criadas estratégias de busca gerais e adaptáveis às bases de dados eletrônicas na área da saúde EMBASE, MEDLINE, CENTRAL (Registro de Ensaios Controlados da Colaboração Cochrane), LILACS e PEDro. Nós incluímos estudos randomizados, nos quais os pacientes com PND foram alocados a participar ou não de um programa pré-determinado e supervisionado de atividade física. Os desfechos primários foram: número de quedas, melhora do risco de cair (aferida pelo Teste de Alcance Funcional (TAF), Teste Get Up and Go (TUG), Escala de Equilíbrio de Berg (EEB), estabilometria, apoio unipodal) e melhora do medo de cair (mensurada pelo Fall Efficacy Scale International – FES-I). Os desfechos homogêneos e com a mesma unidade de medida em pelo menos dois estudos foram plotados em uma metanálise, utilizando-se o software Review Manager 5.3. A qualida... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: In addition to acute complications related to hyperglycemia, patients with Diabetes Mellitus develop several chronic complications throughout life that together contribute to greater morbidity and mortality in these individuals. Peripheral Diabetic Polyneuropathy (PND) is one of these complications, which, in addition to symptoms of paresthesia and hyperesthesia, and several types of spontaneous pain, can lead to a decrease in postural balance and an increased risk of falls. Objective: We performed a systematic review to evaluate the effectiveness of pre-programmed and supervised physical activity in the complementary treatment of PND. Methods: General and adaptive search strategies were created for electronic databases in the health area; Embase, Medline, CENTRAL-Cochrane, Lilacs, and PEDro. We included randomized trials in which patients with PND were allocated to participate or not in a pre-determined and supervised program of physical activity. The primary outcomes were: number of falls, improvement in the risk of falls (measured by the Functional Reach Test (FRT), Get Up and Go Test (TUG), Berg Balance Scale (BBS), stabilometry, and one leg stance test) and improvement in fear of falling (measured by the Fall Efficacy Scale International – FES-I). The homogeneous outcomes, with the same unit of measurement in at least two studies were plotted in a meta-analysis, using the software Review Manager 5.3. The quality of evidence was generated in accordance w... (Complete abstract click electronic access below) / Doutor

Made available in DSpace on 2015-07-22T20:50:53Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-04-29. Added 1 bitstream(s) on 2015-08-11T03:26:20Z : No. of bitstreams: 1 Publico-165a.pdf: 463473 bytes, checksum: cae240c8ee591f50351d96ca3258bfba (MD5). Added 1 bitstream(s) on 2015-08-11T03:26:20Z : No. of bitstreams: 2 Publico-165a.pdf: 463473 bytes, checksum: cae240c8ee591f50351d96ca3258bfba (MD5) Publico-165b.pdf: 155628 bytes, checksum: 1115706461101400dcec7e30309c015b (MD5). Added 1 bitstream(s) on 2015-08-11T03:26:20Z : No. of bitstreams: 3 Publico-165a.pdf: 463473 bytes, checksum: cae240c8ee591f50351d96ca3258bfba (MD5) Publico-165b.pdf: 155628 bytes, checksum: 1115706461101400dcec7e30309c015b (MD5) Publico-165c.pdf: 1838976 bytes, checksum: 98bc6262f927468869ae5e34cde1918a (MD5). Added 1 bitstream(s) on 2015-08-11T03:26:20Z : No. of bitstreams: 4 Publico-165a.pdf: 463473 bytes, checksum: cae240c8ee591f50351d96ca3258bfba (MD5) Publico-165b.pdf: 155628 bytes, checksum: 1115706461101400dcec7e30309c015b (MD5) Publico-165c.pdf: 1838976 bytes, checksum: 98bc6262f927468869ae5e34cde1918a (MD5) Publico-165d.pdf: 1269518 bytes, checksum: f1bbb32c8edea554dfa6517033d47653 (MD5). Added 1 bitstream(s) on 2015-08-11T03:26:20Z : No. of bitstreams: 5 Publico-165a.pdf: 463473 bytes, checksum: cae240c8ee591f50351d96ca3258bfba (MD5) Publico-165b.pdf: 155628 bytes, checksum: 1115706461101400dcec7e30309c015b (MD5) Publico-165c.pdf: 1838976 bytes, checksum: 98bc6262f927468869ae5e34cde1918a (MD5) Publico-165d.pdf: 1269518 bytes, checksum: f1bbb32c8edea554dfa6517033d47653 (MD5) Publico-165e.pdf: 1520227 bytes, checksum: 275186328f675001df3bba84180ce117 (MD5) / Contexto: A síndrome das pernas inquietas (SPI) é uma desordem caracterizada por uma angustiante necessidade de movê-las e, às vezes, mover também outras partes do corpo, geralmente acompanhada de desconforto ou dor. O tratamento desta síndrome com agonistas dopaminérgicos tem sido reconhecido como terapêutica de primeira linha, porque parece eficaz com base em princípios fisiopatológicos; vários grupos farmacológicos compreendem seu tratamento. Objetivos: Avaliar se intervenções farmacológicas são eficazes e seguras para o tratamento da SPI. Método: Revisão Sistemática Cochrane de estudos randomizados ou quasirandomizados sobre agentes farmacológicos utilizados no tratamento da SPI. Foram avaliados os seguintes desfechos para cada fármaco: alívio dos sintomas medido pela escala de gravidade para a síndrome das pernas inquietas (IRLSSG Rating Scale), eventos adversos, parâmetros polissonográficos, melhora subjetiva, qualidade de vida, impressão clínica global, impressão global do paciente, escala de sonolência de Epworth MSLT: Múltiplos Testes de Latência do Sono; PLMI: índice dos Movimentos Periódicos dos Membros. A autora desta tese avaliou os estudos recuperados nas buscas, utilizando critérios que envolviam os métodos randômicos, de cegamento e sigilo de alocação. As divergências foram resolvidas em reunião de consenso. Resultados: As buscas manual e eletrônica encontraram 1.026 estudos. Foram incluídos 94 ensaios clínicos que atendiam aos critérios de inclusão (estudos randomizados ou quasi-randomizados). A análise dos dados considerados em conjunto permitiu concluir que as intervenções farmacológicas foram efetivas para os agonistas dopaminérgicos. Dentre as drogas de segunda linha, apenas a clonidina mostrou-se efetiva. A qualidade dos estudos foi adequada para os ensaios clínicos envolvendo os agonistas dopaminérgicos, parcialmente adequada para levodopa e anticonvulsivantes e pouco adequada para os demais fármacos estudados. Conclusões: Há evidências de que os agonistas dopaminérgicos são eficazes e seguros para o tratamento da SPI a curto prazo, mas não há evidência científica de que os demais fármacos são efetivos nesta doença. / Background: The restless legs syndrome (RLS) is a disorder characterized by a distressing need to move the legs and sometimes other parts of the body. Usually accompanied by a marked sense of discomfort or pain in the leg or other body part affected. The treatment of restless legs syndrome with dopamine agonists has been recognized as the main first-line treatment because it seems to be effective based on pathophysiologic principles. Although, several pharmacological drugs are envolved in the treatment of RLS. Objectives: To assess whether pharmacological interventions are effective and safe for the treatment of RLS. Methods: Systematic Cochrane Review of randomized studies or quasi-randomized on pharmacological agents used to treat RLS. The following outcomes were assessed for each drug: relief of symptoms measured by the restless legs syndrome ranting scale (IRLSSG Rating Scale), adverse events, polysomnographic parameters, subjective improvement, quality of life and clinical global impression, overall impression of the patient , the scale of Epiworth MSLT: Multiple Sleep Latency Test; PLM periodic limb movments and others. The authors evaluated the studies retrieved in searches using criteria involving the method of randomization, blinding and the method of allocation concelment. Disagreements were resolved by consensus. Results: The electronic and manual search found 1,026 studies. Were included 94 studies that met the clinical criteria for inclusion (randomized studies or quasi-randomized). The analysis of data, taken together, indicated that the pharmacological interventions were effective for dopamine agonists. Among the second-line drugs, only clonidine was shown to be effective. The quality of studies was suitable for clinical trials involving the dopamine agonists, partially adequated to levodopa and anticonvulsants, and unsuited for the other drugs studied. Conclusions: There is evidence that dopamine agonists are effective and safe for the treatment of RLS in the short term, there is no scientific evidence that all drugs are effective in this disease. / TEDE / BV UNIFESP: Teses e dissertações

Background: Pain is frequently reported by people with multiple sclerosis (MS). It has been associated with decreased quality of life, psychiatric morbidity, interference with day to day activities, and frequent healthcare attendance. It has been reported by people with multiple sclerosis to be one of their most important symptoms, and available treatments are limited in their effectiveness. Despite this, our understanding of the epidemiology and mechanisms of pain in people with MS are limited. Our understanding of the interactions of central nervous system mechanisms and pain states overall is growing. However, the application of this knowledge to MS is incomplete. Previous studies have shown that the descending pain modulatory system (DPMS) is an endogenous network of cortical and subcortical brain structures which act to limit, or accentuate, an individual’s perception of pain, via descending brainstem pathways. Associated clinical measures include depression, anxiety, and cognitive flexibility. Our understanding of the function or dysfunction of this system in MS is limited. We do not know if the MS disease process may adversely affect the structure or function of the DPMS. Hypothesis: In people with neuropathic limb pain in relapsing remitting MS (RRMS), compared to people with RRMS who do not have pain, there will be disruption of the endogenous descending pain modulatory system. This will manifest as impaired descending inhibition of pain. Aims and Methods Establishing the background using systematic reviews: The first aim of this thesis was to establish the prevalence, natural history and associations of pain (and pain syndromes) occurring in people with MS. The second aim was to explore existing knowledge of how the MS disease process may contribute to pain states, using a systematic review of neuroimaging studies. Prospective clinical study: A case-control study of 47 people with RRMS was then carried out. 31 of these had neuropathic pain in the limbs, and 16 did not have pain. Using targeted assessments, function of the descending pain modulatory system was assessed in the following ways: First: Detailed clinical, behavioural and neuropsychological assessment, focussing on cognitive, behavioural and affective features known to be closely related to the DPMS. Second: MRI imaging of brain structure, focussing on the volume and location of MS lesions, as well as the volume of key grey-matter structures involved in the DPMS. Third: Resting state functional MRI imaging of the brain, focussing on functional connectivity between the rostral anterior cingulate cortex and two other key DPMS structures (dorsolateral prefrontal cortex, and periaqueductal gray). Results: Systematic reviews: Meta-analysis of existing prospective studies confirmed that pain is very common in MS, affecting about 63% of people with MS on average (95%CI between 55 and 70%). Many different types of pain contribute to this overall estimate. No significant associations with disease course or stage emerged. Several neuroimaging studies have assessed people with MS-associated pain using MRI. These studies were often small, and with associated methodological issues. It is likely that location of MS lesions is implicated in aetiology of pain syndromes in some cases, though our overall knowledge is limited. Prospective study: In a prospective study, people with and without pain were matched for age and gender. Furthermore, groups were balanced for a range of other variables. The pain group more frequently received gabapentinoid medications. The presence of pain was significantly associated with increased scores for depression, fatigue and catastrophising, as well as with specific impairments at neuropsychological assessment, including cognitive flexibility. Many of these impairments are directly relevant to existing models of the DPMS. Overall volume of MS lesions was not different in people with pain, though lesions were more likely to occur in the brainstem. Some alterations of grey-matter volumes in people with pain which mirrored studies of pain disorders outside MS were found, but these did not involve structures key to the DPMS. Affected structures included trigeminothalamic nucleus (relative volume increase in pain group), posterior cingulate cortex and parahippocampal gyrus (volume decrease in pain group). Functional connectivity of the rostral anterior cingulate cortex to the periaqueductal grey matter, a key structure in the descending modulation of pain, was stronger in the group without pain. Conversely, functional connectivity to the dorsolateral prefrontal cortex, repeatedly implicated in the DPMS and thought to be involved in cognitive evaluation and flexibility, was stronger in the pain group. MS lesion volume appeared to account for some of this difference in a multivariate analysis. Limitations: Key limitations of this work include cross-sectional design, small sample size, and number of statistical comparisons carried out. Conclusions: Systematic reviews examined the prevalence, natural history and associations of pain in MS, as well as examining existing neuroimaging studies which investigated how the MS disease process could contribute to pain states. A prospective study found evidence of both emotional/affective and cognitive dysfunctions relevant to the hypothesis of dysfunction in the DPMS. Higher likelihood of MS lesions in the brainstem could be relevant to DPMS function. Separately, there were structural grey-matter volume alterations reflecting those found in many pain studies outside MS. Importantly, however, these did not affect key DPMS structures. Resting state functional MRI however demonstrated altered connectivity of core DPMS structures, which may be partly mediated by MS lesion volume. Functional connectivity findings could be consistent with the hypothesis of impaired descending pain inhibition, in people with relapsing remitting MS affected by neuropathic limb pain.

Introduction: There is an increased acceptance and demand for online and mobile health (mHealth) interventions to support physical and mental health problems. However, the uptake and engagement of these interventions is relatively low and the evidence base for these interventions requires continual updating in line with technological advances. A systematic review was conducted, focusing on anxiety and depression, to explore the existing evidence base of both physical health and mental health mobile applications. The first research paper explores the acceptability of mHealth interventions for both mental health and physical health problems. The final research paper explores use and strategies when searching for mental health information online. Additionally, perceived quality, sentiment and barriers to online health information was explored. Methods: Studies were identified by searching for articles published between January 2008 and January 2016. Databases included: PsycINFO, MEDLINE, CINAHL PLUS and the Cochrane Central Register of Controlled Trials for 2016. In the research articles, 218 people completed an online survey in January 2016 exploring, online health seeking for mental health and physical health problems, and acceptability of mHealth interventions. Sentiment of online health resources was explored by extracting 432 individual tweets from Twitter. Results: The systematic review revealed twenty-seven studies for inclusion; 10 with a physical health focus and 17 with a mental health focus. Targeted depression applications have the superior evidence base; however, no firm conclusions can be made regarding interventions that targeted physical health, or those measuring anxiety. The first research paper found that face-to-face therapy would more likely meet expectations for treatment of both physical and mental health problems compared to mHealth interventions. Computerised interventions were more likely to meet expectations than mobile applications. Expectations of treatment were higher for the treatment of mental health problems than physical health problems. The second research paper found that a large proportion of the public use the internet to search for information on mental health, with half citing it as their primary source for mental health information. The online survey found that the quality of mental health information available on the internet was rated favourably, compared to mobile applications. Overall, the sentiment towards specific online mental health resources was generally positive. Conclusions: Research into online and mHealth interventions has developed considerably in recent years in line with advances in technology. These interventions have the potential to be an effective treatment of common mental health problems. The systematic review highlighted that depression applications are more established and effective than applications targeting anxiety. The first research paper suggests that mHealth interventions fall short of public expectations for treatment of health problems. The final research paper reflects that the perceived quality of online mental health information is rated favourably. However, many barriers still limit uptake. Future research could focus on continually developing and evaluating evidence based online and mHealth interventions and the outcome of this study suggests that incorporating them more widely into existing care systems, alongside face to face interventions could increase the public’s confidence in these interventions.

Magister Artium - MA (Psychology) / Honours students in Psychology typically form larger cohorts with numbers ranging from 20 to 40 students in comparison to other disciplines that have fewer than 10 students in a cohort. The National Qualifications Framework (NQF) requires Honours students to complete a thesis that is equivalent to 300 notional hours or 30 credits. The learning outcome is that students conduct low level research that prepares them for conceptualizing, executing and writing up a research project. The thesis requirement should also prepare them for future studies. The larger cohorts and revised NQF thesis requirement places increased pressure on the staff compliment of Psychology departments. Some of the ways in which departments have attempted to cope with this increased demand include conducting group-based research projects, and secondary research projects. One of the concerns raised is whether these particular types of methodology prepared students adequately for reactive research in further studies. This study aimed to explore students' subjective perceptions about the extent to which group-based systematic review methodology in the Honours year adequately prepared students for conducting research during their masters-level studies. An explorative study was conducted to explore the experiences of purposively selected recent graduates from two identified Honours programmes that have progressed to Masters level studies. Participants were invited on the basis of being graduates or alumni rather than their registration status as Masters students at particular universities.

Background: Antibiotics are prescribed frequently for upper respiratory tract infections (URTIs) despite the fact that most of them do not require antibiotics. This over-prescription contributes to antibiotic resistance which is a major health problem. Physicians perceive that patients’ expectations influence their antibiotic prescribing practice. Methods: As the first phase of the thesis, we conducted a systematic review to determine the effectiveness of patient-oriented interventions to reduce unnecessary use of antibiotics for URTIs. As the second phase, we conducted a qualitative descriptive study to explore patients’ views about URTIs and identify ways they manage them by using semi-structured interviews based on Common Sense-Self-Regulation Model (CS-SRM). Results: Our systematic review included 14 studies which based on their interventions were classified into two major categories: delayed prescriptions and patient/public information and education interventions. Our meta-analysis revealed that almost all studies with delayed prescription significantly reduced use of antibiotics for URTIs. Our subgroup analysis showed that prescriptions that were given at a later time and prescriptions that were given at the index consultation had similar effects regarding antibiotic use. The small number of included studies in the patient/public information and education group did not allow us to make a definite conclusion on their effectiveness. For the qualitative study, 15 individuals were interviewed. almost all participants mentioned that they only visited their doctor if their symptoms got progressively worse and they could no longer self-manage URTI symptoms. When visiting a doctor, most participants reported that they expected to receive an examination and an explanation for their symptoms. Discussion: Patient-oriented interventions (especially delayed prescriptions) may be effective in reducing antibiotic use or prescription for URTIs in patients. Further research is needed to investigate the costs and feasibilities of implementing these interventions as part of routine clinical practice. Our participants reported good knowledge regarding the likely lack of benefit from antibiotics for URTIs. The results suggest a discrepancy between our participants’ reported reasons for visiting doctors and doctors’ perceptions about patients’ reason for their visit identified in previous studies. Focusing on interventions that facilitate the communication between patients and doctors, instead of providing more education to public may help in reducing the use of unnecessary antibiotics.

Introdução: Rupturas do tendão calcâneo (TC) afetam 18 em 100.000 pessoas todos os anos. A mobilização precoce vem sendo preconizada como uma estratégia eficaz para acelerar o processo de recuperação funcional. Entretanto, a escolha do método de reabilitação após o reparo cirúrgico permanece controversa devido à ausência de evidências clínicas. Objetivo: Verificar o efeito de intervenções aceleradas e tradicionais de fisioterapia em indivíduos que realizaram sutura do TC, por meio de revisão sistemática com metanálise. Metodologia: A busca incluiu as bases de dados MEDLINE (via PubMed), EMBASE, Cochrane CENTRAL, Scopus, Science Direct, Lilacs, PEDro, além de busca manual de artigos científicos até início de janeiro de 2014. Foram incluídos ensaios clínicos randomizados e não randomizados comparando intervenções aceleradas e tradicionais após sutura do TC sobre as variáveis: força muscular, amplitude de movimento (ADM) e capacidade funcional do tornozelo. Dois revisores independentes avaliaram os estudos de acordo com critérios de inclusão e exclusão pré-estabelecidos. Resultados: Dos 2194 artigos identificados, 8 estudos foram incluídos. A revisão sistemática evidenciou alta variabilidade entre os estudos em relação as intervenções de fisioterapia. Quanto à metanálise, realizamos a avaliação dos desfechos no período de 6 meses de pós-operatório devido a ausência de dados dos mesmos em outros períodos. Na comparação entre diferentes intervenções de fisioterapia não foram observadas melhoras significativas em relação a variável força muscular (-19,66; IC95%: -74,03 a 34,71) assim como na ADM de flexão plantar (-0,05; IC95%: -3,07 a 2,97) e flexão dorsal (1,94; IC95%: -2,12 a 5,99). Conclusão: A intervenção acelerada de fisioterapia não apresentou melhora significativa da força muscular e na ADM após sutura do TA aos 6 meses de pós-operatório. / Introduction: Achilles tendon (AT) ruptures affect 18 in 100,000 people each year. Early mobilization has been recommended as an effective strategy for accelerating functional recovery. However, the choice of the best rehabilitation method after surgical repair remains controversial due to the absence of clinical evidence. Objective: To investigate the effect of traditional and accelerated rehabilitation protocols on plantiflexores muscular strength, ankle range of motion (ROM) and ankle functional capacity in subjects who underwent Achilles tendon suture, through a systematic review with meta-analysis. Methodology: The search included MEDLINE (via PubMed), EMBASE, Cochrane CENTRAL, Scopus, Science Direct, LILACS, PEDro, and manual search of manuscripts until January 2014. Randomized and non-randomized clinical trials were included comparing traditional and accelerated rehabilitation protocols after AT suturing on the following variables: muscle strength, ankle ROM and functional capacity. Two independent reviewers assessed studies according to inclusion and exclusion criteria previously established. Results: Of the 2194 articles identified, 8 studies were included. High variability between studies in relation to the rehabilitation protocols was observed in the systematic review. As for the meta-analysis, we conducted an evaluation of the outcomes up to 6 months postoperatively due to missing data from these outcomes at other time periods. When comparing the different rehabilitation protocols, no significant improvements were observed in muscle strength (-19.66, 95% CI -74.03 to 34.71) as well as in plantarflexor (-0.05; 95 %: -3.07 to 2.97) and dorsiflexor (1.94, 95% CI: -2.12 to 5.99) ROM. Conclusion: The accelerated protocol showed no significant improvement in muscle strength and ROM at 6 months post-surgical repair of the AT.

Introdução A prevalência de sobrepeso e obesidade em adolescentes brasileiros tem sido investigada em diferentes regiões e períodos do tempo. Estudos observacionais de base escolar apresentam baixo custo e são facilmente conduzidos, comparativamente a estudos de base populacional, que requerem maior custo e tempo. Objetivos Comparar medidas sumárias de prevalências de sobrepeso e obesidade no Brasil, obtidas em metanálise de estudos observacionais de bases escolar e populacional, realizados em amostras aleatórias. Métodos Bases de dados Medline, Embase, Lilacs, IBECS, Scielo, Adolec e Banco de Teses da Capes foram revisadas sistematicamente, buscando-se estudos de prevalência de sobrepeso e obesidade realizados no Brasil, em adolescentes, com 10 a 19 anos, entre 1990 e 2010. Estudos de prevalência, transversal ou de coorte, publicados em revistas com “peer review” e na literatura “cinza”, foram identificados por dois revisores independentemente, a partir de título e resumo, e, após comparação, um terceiro decidiu discordâncias. Dados foram extraídos por dois pesquisadores independentes utilizando protocolo padronizado, discordâncias decididas por consenso ou árbitro. A classificação de sobrepeso, obesidade e/ou excesso de peso foi definida pelos critérios utilizados em cada estudo. A análise dos dados utilizou modelo aleatório, realizada no Software 6 Comprehensive Meta-Analysis 2.0®. Resultados Entre 1939 artigos elegíveis, 138 preencheram os critérios de inclusão, 58 foram excluídos, sendo 30 exclusões pelo motivo de dados em duplicata, 17 por não utilizarem amostras aleatórias populacionais ou escolares representativas e 11 por não apresentarem os dados requeridos no protocolo da metanálise. Vinte e cinco estudos foram considerados perdas por não apresentarem a prevalência de obesidade em adolescentes, após três tentativas de contato com os autores. Dos 55 estudos incluídos na metanálise, 14 eram estudos observacionais com amostras de base populacional e 41 de base escolar. A prevalência de sobrepeso e obesidade em adolescentes encontrada em estudos de base populacional foi 16,7% (95% CI: 13,2-20,8) e 5,5% (95% CI: 4,2-7,1) e nos de base escolar foi 11,9% (95% CI: 10,3-13,3) e 5,1% (95% CI: 4,3-6,0), respectivamente. A heterogeneidade encontrada nos estudos de base populacional foi Q=8,17 (P < 0,001) para sobrepeso e Q=5,88 (P < 0,001) para obesidade, enquanto nos de base escolar foi Q=30,6 (P < 0,001) e Q=33,6 (P < 0,001), respectivamente. Apesar dos estudos com amostras de base escolar mostrarem maior inconsistência dos resultados quando comparados com os estudos de amostra de base populacional (I²=7,74 vs. 0), esses valores não são considerados altos. Conclusão Estudos com amostras de adolescentes de base populacional e escolar apresentam estimativas pontuais similares de prevalência de obesidade, porém apresentam diferenças nas prevalências pontuais de sobrepeso. / Introduction In Brazil, overweight and obesity prevalence in adolescents has been investigated in different regions and periods of time. Studies of school-based samples have low cost and are easily conducted, being widely used. Otherwise, population-based studies require greatest investments, more time and researches, besides high complexity to minimize bias. Objective To undertake meta-analysis of observational studies conducted in Brazilian adolescents to calculate pooled estimates for overweight and obesity prevalence for school-based versus population-based samplings. Methods Data sources included Medline, Embase, Bireme, and CAPES-Thesis database searching for articles and grey literature about overweight and obesity prevalence in adolescents aged 10 to 19 years, from studies conducted in Brazil from 1990 to 2010. Studies were systematically reviewed, with no language restriction, and independently extracted by two investigators using a standardized protocol. Overweight, obesity and/or overweight plus obesity were defined according to the criteria used in each study. Data analysis was performed by Comprehensive Meta-Analysis 2.0®, using random effect model. Results Among 1939 articles reviewed, 138 met the inclusion criteria, 58 were excluded, and 25 were not retrieved after three attempts to contact authors. Among 55 studies included in meta-analysis 14 were population-based and 41 school-based samples. Overweight and obesity prevalence in population-based studies was 16.7% (95% CI: 13.2-20.8) and 5.5% (95% CI: 4.2-7.1) and in school-based studies it was 11.9% (95% CI: 10.3-13.3) and 5.1% (95%CI: 4.3-6.0), respectively. The heterogeneity founded in population-based studies was Q = 8.17 (P < 0.001) for overweight and Q = 5.88 (P < 0.001) for obesity, while in school-based studies it was Q=30.6 (P < 0.001) and Q=33.6 (P < 0.001), respectively. Although school-based studies showed higher inconsistency measure in the results compared with population-based samples studies (I²=7,74 vs. 0), these values are not considered high. Conclusion School-based studies as well population-based studies conducted in adolescents provide similar point estimate of obesity prevalence, but there is a difference for point prevalence of overweight.

Introdução: A Síndrome Metabólica (SM) tem sido associada à proteinúria a redução da taxa de filtração glomerular. Em transplantados renais a imunossupressão aumenta a incidência de fatores de risco cardiovasculares, predispondo à síndrome. O objetivo dessa revisão sistemática e metanálise é buscar informações precisas, visando esclarecer qual o impacto da SM no pós- transplante. Métodos: Estratégias de buscas foram utilizadas no MEDLINE, no EMBASE e na Cochrane Library até o dia 4 de Outubro de 2014. Foram selecionados estudos que compararam indivíduos com e sem SM, submetidos a transplante renal e que avaliaram os seguintes desfechos: perda de enxerto, eventos cardiovasculares (ECV), morte por doença cardiovascular (DCV) e morte por todas as causas. Dois revisores independentes extraíram os dados e avaliaram a qualidade dos estudos. Resultados: Dos 585 estudos inicialmente identificados, 5 foram selecionados, incluindo um total de 1269 pacientes. A SM mostrou-se associada à perda de enxerto (risco relativo, 3,02; intervalo de confiança (IC) 95%,2,17-4.32; I²=0%; P heterogeneidade= 1,35), ECV (risco relativo, 3,53; IC95%, 1,27-9.85; I²= 0%; P heterogeneidade= 1,81) e morte por DCV (risco relativo, 2,61; IC 95%, 0,70-9,81; I²=58%; P heterogeneidade= 0.76). Não foi encontrada associação entre a SM e morte por todas as causas. Conclusão: Encontrou-se associação entre perda de enxerto, ECV e morte por DCV com o diagnostico de SM após transplante renal. Estudos com maior tamanho amostral e poder devem ser realizados para que se possa avaliar a possível associação entre mortalidade por todas as causas e SM após o transplante renal. Há necessidade de estudos clínicos randomizados a fim de verificar se intervenções em cada componente da síndrome resultariam em melhores desfechos após o transplante renal. / Background: Metabolic syndrome (MS) has been associated with proteinuria and reduced glomerular filtration rate. Immunosuppressive agents increase the incidence of traditional cardiovascular risk factors and thus have expected effects on components of MS after transplantation. The purpose of this systematic review and meta-analysis is provide valid information regarding the syndrome and clarify this question. Methods: MEDLINE, EMBASE and Cochrane Library were searched up to October 4, 2014. Papers that compared MS and non-MS patients who underwent renal transplantation and assessed one of the following outcomes: graft loss, cardiovascular events (CVE), death by cardiovascular disease (CVD) and all-cause-mortality were included. Two independent reviewers summarized the data and evaluated the quality of the articles. Results: From 585 studies identified, 5 were included (1269 patients). MS was related to graft loss (relative risk, 3.02; 95% confidence interval, 2.17-4.32; I²= 0%; P heterogeneity= 1.35), CVE (relative risk, 3.53; 95% confidence interval, 1.27-9.85; I²= 0%; P heterogeneity= 1.81) and death by CVD (relative risk, 2.61; 95% CI, 0,70-9,81; I²=58%; P heterogeneity= 0.76). No association was found between MS and all cause-mortality. Conclusion: Graft loss, CVE and death by CVD were associated with the MS diagnoses after kidney transplantation. Larger studies should be design to elucidate its association with mortality by all-causes, since the combined sample size from the available studies still lack power. Lastly, prospective randomized clinical trials should be conducted in order to define if interventions on each MS component would result in better outcomes after kidney transplantation.